Regadenoson Injection, Solution
Product Images NDC 71288-201

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Regadenoson (NDC 71288-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Regadenoson Carton (Reg Carton 03.2021 V2)

FDA Label Image

Regadenoson Syringe (Reg Syringe V2)

Regadenoson Syringe (Reg Syringe V2)
This is a description of a medication with the NDC number of 71288-201-85. It is an injection with a concentration of 0.4 mg per 5 mL, or 0.08 mg per mL. The medication is for pharmacologic stress only and is for intravenous use only. It comes in a 5 mL single-dose pre-filled syringe and any unused portions must be discarded. There is information about the manufacturer, Meitheal Pharmaceuticals, located in Chicago, IL.*
FDA Label Image

Structural Formula (Reg05 0001 01)

FDA Label Image

Logo (Reg05 0001 02)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.